These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 7691696

  • 1. [A new AIDS drug in evaluation].
    Fortschr Med; 1993 Aug 30; 111(24):12. PubMed ID: 7691696
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FDA Advisory Committee stalemates on delavirdine.
    AIDS Patient Care STDS; 1997 Apr 30; 11(2):96-7. PubMed ID: 11361773
    [No Abstract] [Full Text] [Related]

  • 5. Expanded access for delavirdine.
    Posit Aware; 1996 Apr 30; 7(3):5-6. PubMed ID: 11363426
    [Abstract] [Full Text] [Related]

  • 6. Confirmation for combination AIDS therapy.
    Science; 1995 Oct 06; 270(5233):33. PubMed ID: 7569948
    [No Abstract] [Full Text] [Related]

  • 7. [AIDS: therapeutic changes in the second decade. Triple combination--HIV vaccination].
    Jäger H.
    Fortschr Med; 1993 May 30; 111(15):20-1. PubMed ID: 8330817
    [No Abstract] [Full Text] [Related]

  • 8. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan 30; 92(8):407. PubMed ID: 8582889
    [No Abstract] [Full Text] [Related]

  • 9. Study results at a glance.
    AIDS Alert; 1995 Nov 30; 10(11):134. PubMed ID: 11362922
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delavirdine/protease inhibitor interactions.
    Gilden D.
    GMHC Treat Issues; 1996 Sep 30; 10(9):11-2. PubMed ID: 11363839
    [Abstract] [Full Text] [Related]

  • 12. Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.
    Morse GD, Fischl MA, Shelton MJ, Cox SR, Driver M, DeRemer M, Freimuth WW.
    Antimicrob Agents Chemother; 1997 Jan 30; 41(1):169-74. PubMed ID: 8980774
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine.
    Chong KT, Pagano PJ.
    Antiviral Res; 1997 Mar 30; 34(1):51-63. PubMed ID: 9107385
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr 30; 10(4):8. PubMed ID: 11363709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Update on reverse transcriptase inhibitors in HIV disease.
    Carr A, Loewenthal M, Cooper DA.
    Isr J Med Sci; 1993 Oct 30; 29(10 Suppl):26-30. PubMed ID: 7503966
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.